New Edition of Online Tool to Measure Cancer Progress to Launch at World Cancer Congress
The new CII will be featured at WCC in a poster presentation entitled, "Assessing the Evidence Supporting New Cancer Treatments: Phase III and Beyond." A presentation of the poster will take place on
Advancing the value discussion in cancer care
"Cancer is a very complex disease and most progress against it has not resulted from major breakthroughs, but rather, from continuous innovation or step-by-step advances over time," said
According to
"This historical perspective and the reality of progress in cancer care are currently missing from the value frameworks," said
Advocacy community reaction to the new CII has been very positive to date. Following is a sampling of feedback:
- "The CII consolidates a vast amount of information into an easy-to-interpret visual," said
Lynn M. Matrisian , PhD, MBA, Chief Research Officer,Pancreatic Cancer Action Network . "We are excited about using it to better see where progress is being made against cancer and where we can make future advancements."
- "The visuals of the CII are very helpful to get a quick overview of where we are in the fight against cancer," said
Pam Traxel , Vice President,Alliance Development & Philanthropy ,American Cancer Society Cancer Action Network .
Advancing our knowledge of cancer progress
The CII enables users to: visualize progress against cancer over time; gain a better understanding of the evolution of cancer treatment progress and value; and consider the potential impact of policy reforms that affect the speed of continuous innovation and patient access. The new version of the tool provides enhanced data comparison capabilities in a total of 12 tumor types: breast, colorectal, endometrial, gastrointestinal stromal, kidney, liver, lung, pancreatic, prostate, skin (melanoma), stomach, and testicular.
At the heart of the CII are thousands of pieces of evidence curated and coded by trained analysts from authoritative, published sources, such as clinical trial records and meta-analyses, observational studies and historical references. The tool, which provides a layered interface with a range of information, generates summary graphs from which a user can access supporting evidence and additional information. The CII is available for use at no cost through an interactive online interface at www.pacenetworkusa.com/continuousinnovation.php.
About PACE
PACE, now in its fifth year, is a global collaboration that encourages public policies and healthcare decisions that speed the development of new medicines, assure cancer treatments respond to the needs and qualities of individual patients, and improve patient access to the most effective cancer medicines. PACE engages key oncology stakeholders, including: patients, advocacy, payers, policymakers, providers, the public, researchers and politicians. To learn more about PACE, please visit www.pacenetwork.com.
About Lilly Oncology
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world.
About Eli Lilly and Company (NYSE:LLY)
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.
P-LLY
Refer to:
Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-edition-of-online-tool-to-measure-cancer-progress-to-launch-at-world-cancer-congress-300353502.html
SOURCE
News Provided by Acquire Media